Patent details

EP3119431 Title: ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME

Basic Information

Publication number:
EP3119431
PCT Application Number:
US2015021887
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157652876
PCT Publication Number:
WO2015143409
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME
French Title of Invention:
ANTICORPS ANTAGONISTES DIRIGÉS CONTRE LE PEPTIDE LIÉ AU GÈNE DE LA CALCITONINE ET LEURS PROCÉDÉS D'UTILISATION
German Title of Invention:
ANTAGONISTISCHE ANTIKÖRPER GEGEN CALCITONINGEN-ASSOZIIERTES PEPTID UND VERFAHREN DAMIT
SPC Number:

Dates

Filing date:
20/03/2015
Grant date:
24/01/2024
EP Publication Date:
25/01/2017
PCT Publication Date:
24/09/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/01/2024
EP B1 Publication Date:
24/01/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/03/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/01/2024
 
 

Name:
Teva Pharmaceuticals International GmbH
Address:
Schlüsselstrasse 12, 8645 Rapperswil-Jona, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
25/01/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WALTER, Sarah
Address:
United States (US)

2

Name:
CHANG, Michael
Address:
United States (US)

3

Name:
STERN, Henry
Address:
United States (US)

4

Name:
BIGAL, Marcelo
Address:
United States (US)

Priority

1

Priority Number:
201461968897 P
Priority Date:
21/03/2014
Priority Country:
United States (US)

2

Priority Number:
201462083809 P
Priority Date:
24/11/2014
Priority Country:
United States (US)

3

Priority Number:
201562119778 P
Priority Date:
23/02/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395;

Publication

European Patent Bulletin

Issue number:
202404
Publication date:
24/01/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Expected Payer:
Last Annual Fee Payment Date:
18/02/2025
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
25/01/2024 Power Of Attorney 1
25/01/2024 Outgoing Correspondence 1